| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |